# Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective.

> PubMed lists PMID 42076118 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-04-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42076118-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-13
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42076118-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42076118-semaglutide-v1.json
- Content SHA-256: `579d5409165ff4dfeb6f51a8c8581ba699f8802b353c69d9db92432452f6253e`

## Claims and source pins

### Headline

Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective. ([`pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293`](#source-pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293))

### Summary

PubMed lists PMID 42076118 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-04-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293`](#source-pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293))

### Paragraph 1

PubMed lists PMID 42076118 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-04-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293`](#source-pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293`](#source-pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293))

## Sources

<a id="source-pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293"></a>
- **Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective. · retained source version 1:2026-08-13:current:a2c2902cb293dd690ae2c89ab36c9a90ee26ef586cd330a254faaef297b8b48b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42076118/) (`pubmed-observation-pmid-42076118-2026-08-13-a2c2902cb293`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42076118-semaglutide-v1.json SHA-256: 579d5409165ff4dfeb6f51a8c8581ba699f8802b353c69d9db92432452f6253e.